Biochemistry

   

Chronic Lymphocytic Leukemia and Autoimmune Cytopenias: Pathogenesis, Diagnosis and Treatment

Authors: Fergun Yilmaz, Demet Kiper, Filiz Vural

Chronic Lymphocytic Leukemia (CLL) is a clonal proliferation of B cells in bone marrow, lymph nodes, peripheral blood, spleen and other lymphoid tissues. CLL is mostly associated with dysregulated immune system. Intrinsic immune dysfunction results in increased frequency of autoimmune disorders and susceptibility to infections at the time of diagnosis or during course of the disease. Autoimmune cytopenias especially Autoimmune Hemolytic Anemia (AIHA) is observed frequently. AIHA is the most common immune cytopenia ranging between 5-10 % and it is followed by less frequent Immune Thrombocytopenia (IT) (1-5%). Autoimmune Neutropenia (AIN) and Pure Red Cell Aplasia (PRCA) are rare entities (<1%). In CLL patients, the differential diagnosis of autoimmune cytopenias is important since there are many confounding factors which may cause cytopenia in CLL patients such as infiltration of bone marrow by malignant cells, chemotherapy and infections. A careful diagnostic workup should be performed including history taking, physical examination, laboratory tests and bone marrow aspiration and biopsy. The treatment of AIHA and IT is similar to their counter parts primary AIHA and IT where the steroids are the treatment of choice. In PRCA, steroids are mostly ineffective and immunosuppressive agents should be tried. AIN is a very rare entity in CLL patients. Granulocyte stimulating factors, immunosuppressive therapies may be options in symptomatic patients.

Comments: 7 Pages.

Download: PDF

Submission history

[v1] 2017-09-25 02:00:36

Unique-IP document downloads: 4 times

Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.

Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.

comments powered by Disqus